Position in NVS
as of Jun 30, 2026
· filed Aug 20, 2026
Position Value
$454,488
+$11,513 QoQ
Shares Held
2,900
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#931
of 1,603 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Harvest Fund Management Co., Ltd holds $61,466,678 across 9 Drug Manufacturers - General names. NVS ranks #8 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
16,480 | $19,766,608 | |
| 2 | AMGN |
Amgen Inc
|
50,516 | $18,292,853 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
105,327 | $13,307,013 | |
| 4 | ABBV |
AbbVie Inc.
|
29,691 | $7,471,443 | |
| 5 | JNJ |
Johnson & Johnson
|
4,465 | $1,133,976 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
8,547 | $492,478 | |
| 7 | MRK |
Merck & Co., Inc.
|
3,600 | $462,600 | |
| 8 | NVS |
Novartis AG
This page
|
2,900 | $454,488 |
All Filings in NVS
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $454,488 | 2,900 | Shares | Sole | 2026-08-20 | |
| 2026-03-31 | $442,975 | 2,900 | Shares | Sole | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||